Top Markets
#1 QuantixAI QuantixAI +45.25%
#2 MowCat MowCat +27.33%
#3 Prom Prom +22.38%
#4 Tutorial Tutorial +19.96%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +18.39%
#6 UnifAI Network UnifAI Network +17.56%
#7 Versatize Coin Versatize Coin +16.67%
#8 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +15.07%
#9 Pons Pons +12.75%
#10 StonkBroker StonkBroker +10.95%
Coin of the day
QuantixAI QuantixAI
Settings
Language
ENGLISH
Currency
USD
Theme
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Rank in Stocks #20647
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Share Price
$0.517
Last synced: 2026-08-21
Market Cap
$125.14M
Change (1 day)
-0.58%
Change (1 year)
47.71%
Country
US
Trade Vaxart, Inc. (VXRT)

Category

Healthcare
Earnings for Vaxart, Inc. (VXRT)
Earnings in 2026 TTM: 0
According to Vaxart, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Vaxart, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH